Contact Us |

Search 

עברית  

    logoemp

 

slogN

 
 
 

Articles

Professor of Medicine, Head of the Department of Internal Medicine and Vascular Center Franziskus Hospital, Teaching Hospital of Charité – University Medicine Berlin, Germany.

Dr. Schmidt-Lucke is head of one of the biggest vascular medical institutions, comprising more than 100 beds, treating almost 10,000 in and out-patients with vascular disorders per year. He is involved in several clinical cardiovascular trials. He conducted the biggest clinical study so far with autologous stem cell application in PAD. He also served as PI for the phase I study with PLX-cells in CLI.

He trained in Bonn (Germany), London, Aberdeen (UK), Basel and Zurich (Switzerland) and received his medical degree from Bonn University Medical School, Germany. He completed his residency at the Medical School and Hospital Marburg, Germany. He then performed a 2 year Research fellowship at the Department of Bioengineering and Medical School, University of California, San Diego, La Jolla, CA, USA. After holding consultant positions an Madeburg and Leipzig (Germany) he moved to his present position.
 He received several fellowships and grants from the German National Scholarship Foundation and the German Research Council and was awarded a Science Price from the German Society of Internal Medicine. He is a member of several national and international scientific societies and serves as a reviewer for “VASA”. He published more than 70 articles and books.

Share Button
 

The content, text, graphics, data, and services offered herein (the "Content") are provided solely to educate users of this web site on Pluristem and the goods and/or services it provides.  Nothing in the Content should be considered, or used as a substitute for, medical advice, diagnosis or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.  Reliance on the Content or any portion thereof, or other visitors to the web site, is solely at your own risk.